Breaking Down Boundaries, Enabling Access
Allowing for early screening and imaging from a global health perspective.
Vivo Surgical is a medical technology developer and manufacturer, pioneering devices that empower clinicians to work safely and more efficiently for better clinical outcomes.
​
Our proprietary technologies, which encompass areas from in vivo surgical lighting and portable endoscopy to flexible endoscopic robotics, target unmet clinical needs in the hospital and beyond - positively impacting society and improving lives.
​
Our Technologies
Redefining Diagnostic Access
ENLYT is a portable flexible endoscope system for screening and imaging applications.
®
Unlocking Superior Visibility
KLARO is a highly versatile in vivo surgical lighting device that addresses the challenges posed by current conventional lighting modalities.
®
Democratizing Advanced Endoscopy
ERES™ is a minimally-invasive surgical robotic system that integrates seamlessly with all existing conventional endoscopes. Coming soon.
Our Sustainability Impact
Vivo Surgical is proud to support Plastic Bank – a social enterprise dedicated to
fighting plastic pollution in the ocean.
We have committed to the annual extraction of 1,000 kg of ocean-bound plastic – equivalent to about
10,000 units of our product, KLARO or 50,000 plastic bottles annually.
®
Certifications
Vivo Surgical guarantees that our medical devices comply with all international safety and
regulatory standards.
We work closely with our development and business partners to ensure that our products and services are of the highest quality.
Awards
Vivo Surgical has been recognised as a winner of the prestigious World Intellectual Property Organization – WIPO Global Awards for 2024, selected from over 660 companies across 107 countries.​
​
Such recognition is a testament to the robust intellectual property foundations upon which Vivo Surgical was built. ​​​​​
Vivo Surgical has been recognised as one of the Top 4 Grand Prize Finalists in the MedTech Innovator 5th Annual Asia Pacific Competition. Over 400 companies applied to be part of the 2023 Asia Pacific Accelerator Cohort, from which 24 companies were shortlisted to partake the 4-month accelerator program.
​
As one of the finalists, Vivo Surgical looks forward to gaining valuable insights from the mentorship program and forging strong collaborations with industry stakeholders.
Vivo Surgical has been recognised as an Award Winner in the WIPO-IPOS IP For Innovation Awards.
The WIPO-IPOS IP For Innovation Awards 2022 celebrates Singapore enterprises who have achieved outstanding growth through the successful use of intellectual property (IP).
​
Jointly organised by the Intellectual Property Office of Singapore (IPOS) and the World Intellectual
Property Organization (WIPO), the Awards seek to recognise IP champions who have leveraged the
effective use of IP to innovate, transform and grow their business.